MX2015014450A - Cepa de lactobacillus rhamnosus para regular el metabolismo de lipidos. - Google Patents

Cepa de lactobacillus rhamnosus para regular el metabolismo de lipidos.

Info

Publication number
MX2015014450A
MX2015014450A MX2015014450A MX2015014450A MX2015014450A MX 2015014450 A MX2015014450 A MX 2015014450A MX 2015014450 A MX2015014450 A MX 2015014450A MX 2015014450 A MX2015014450 A MX 2015014450A MX 2015014450 A MX2015014450 A MX 2015014450A
Authority
MX
Mexico
Prior art keywords
lactobacillus rhamnosus
lipid metabolism
rhamnosus strain
regulating lipid
strain
Prior art date
Application number
MX2015014450A
Other languages
English (en)
Inventor
Tamara Smokvina
Johan Van Hylckama Vlieg
Elsa Jacouton
Hervé Blottière
Joel Doré
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Publication of MX2015014450A publication Critical patent/MX2015014450A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere al uso de una cepa de Lactobacillus rhamnosus para prevenir o tratar patologías asociadas con la acumulación excesiva de grasa corporal. Esa cepa se administra de manera preferente de manera oral, en particular en la forma de un alimento o un suplemento alimenticio.
MX2015014450A 2013-04-19 2014-04-18 Cepa de lactobacillus rhamnosus para regular el metabolismo de lipidos. MX2015014450A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1353600A FR3004621B1 (fr) 2013-04-19 2013-04-19 Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique
PCT/IB2014/060841 WO2014170879A1 (fr) 2013-04-19 2014-04-18 Souche de lactobacillus rhamnosus régulatrice du métabolisme lipidique

Publications (1)

Publication Number Publication Date
MX2015014450A true MX2015014450A (es) 2016-05-05

Family

ID=49003844

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014450A MX2015014450A (es) 2013-04-19 2014-04-18 Cepa de lactobacillus rhamnosus para regular el metabolismo de lipidos.

Country Status (6)

Country Link
US (1) US20160074444A1 (es)
EP (1) EP3027061A1 (es)
FR (1) FR3004621B1 (es)
MX (1) MX2015014450A (es)
RU (1) RU2015146979A (es)
WO (1) WO2014170879A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113046276B (zh) * 2021-04-30 2022-03-18 澳优乳业（中国）有限公司 一种母乳源鼠李糖乳杆菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001756B1 (en) * 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
KR100686557B1 (ko) * 2004-08-16 2007-02-23 씨제이 주식회사 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
EP2216035A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus CNCM I-4096 and weight control
FI123157B (fi) * 2009-05-12 2012-11-30 Valio Oy Probioottien uusi käyttö
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system

Also Published As

Publication number Publication date
FR3004621B1 (fr) 2015-05-15
RU2015146979A (ru) 2017-05-24
WO2014170879A1 (fr) 2014-10-23
US20160074444A1 (en) 2016-03-17
FR3004621A1 (fr) 2014-10-24
EP3027061A1 (fr) 2016-06-08

Similar Documents

Publication Publication Date Title
PH12017500680A1 (en) Compositions and methods of use for treating metabolic disorders
PH12017500153A1 (en) Compositions and methods of use for treating metabolic disorders
RS63856B1 (sr) Probiotički sojevi bakterija za prevenciju i lečenje bolesti u usnoj duplji
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
ZA201601119B (en) Strain of lactobacillus pentosus as probiotic
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
AU343147S (en) Easel
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
EA201300175A1 (ru) Таблетка с контролируемым трехфазным высвобождением, содержащая мелатонин, и способ ее изготовления
MX2017008755A (es) Analogos de calcitonina para tratar enfermedades y trastornos.
IL282382A (en) A probiotic supplement for metabolic health containing Lactobacillus
MX368709B (es) Complemento alimenticio para personas con trisomia 21, trastornos del espectro autista y/o trastorno por déficit de atención con o sin hiperactividad.
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
MX2015014450A (es) Cepa de lactobacillus rhamnosus para regular el metabolismo de lipidos.
PH12017500740A1 (en) Nutritional supplements containing a peptide component and uses thereof
MX2016006882A (es) Nutricion infantil para el mejoramiento en la sensibilidad a la insulina mas adelante en la vida.
TW201613489A (en) Hydrolyzed lactose-containing nutritional compositions and uses thereof
PH12015500468A1 (en) Treatment and prevention of acne
CL2015000169A1 (es) Prasterona (dhea) intravaginal para el tratamiento de trastorno hipoactivo del deseo sexual femenino, trastorno de la excitacion sexual femenina, trastorno del orgasmo femenino y trastorno de la excitación interes sexual femenino, en mujeres que no estan sufriendo de sintomas de atrofia vulvovaginal y/o dispareunia de moderada a severa; producto que la comprende.
PH22014000753Y1 (en) Fish canton noodles
PH22014000687U1 (en) Fish and vegetable canton noodles
PH22014000750Y1 (en) Process of preparing fish canton noodles
UA104068C2 (en) Yoghurt
UA92875U (uk) Спосіб профілактики серцево-судинних захворювань
AU359030S (en) A bedside cabinet